Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (131-140 of 508) with videos related to

Pageof 51
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
High Innate Production Capacity of Proinflammatory Cytokines Increases Risk for Death from Cancer: Results of the PROSPER StudyStella Trompet, Anton J M de Craen, Simon Mooijaart, et al.
European Heart Journal|August 29, 2012
Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT StudyJeffrey S Borer, Michael Böhm, Ian Ford, et al.
Circulation|September 8, 2017
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-UpAntonio J Vallejo-Vaz, Michele Robertson, Alberico L Catapano, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 18, 2011
The incidence and risk factors for new onset atrial fibrillation in the PROSPER studyPeter W Macfarlane, Heather Murray, Naveed Sattar, et al.
Journal of Hypertension|June 1, 2014
Effect of vitamin D supplementation on orthostatic hypotension: data from the vitamin D in isolated systolic hypertension randomized controlled trialMiles D Witham, Rosemary J G Price, Allan D Struthers, et al.
Archives of Internal Medicine|November 26, 2008
Statins and blood pressureStella Trompet, J Wouter Jukema, Ian Ford, et al.
BMC Cardiovascular Disorders|May 11, 2007
Does the aldosterone:renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) studyHari K Parthasarathy, Khamis Alhashmi, Alex D McMahon, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 26, 2014
Associations Between Thrombin Generation and the Risk of Cardiovascular Disease in Elderly Patients: Results From the PROSPER StudyRinske Loeffen, Kristien Winckers, Ian Ford, et al.
BMJ Open|September 10, 2016
Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART studyIsla S Mackenzie, Ian Ford, Andrew Walker, et al.
ESC Heart Failure|July 10, 2023
Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial)Amr Abdin, Michel Komajda, Jeffrey S Borer, et al.
Pageof 51

Showing results (131-140 of 508) with videos related to

Sort By:
Pageof 51
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
High Innate Production Capacity of Proinflammatory Cytokines Increases Risk for Death from Cancer: Results of the PROSPER StudyStella Trompet, Anton J M de Craen, Simon Mooijaart, et al.
European Heart Journal|August 29, 2012
Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT StudyJeffrey S Borer, Michael Böhm, Ian Ford, et al.
Circulation|September 8, 2017
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-UpAntonio J Vallejo-Vaz, Michele Robertson, Alberico L Catapano, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 18, 2011
The incidence and risk factors for new onset atrial fibrillation in the PROSPER studyPeter W Macfarlane, Heather Murray, Naveed Sattar, et al.
Journal of Hypertension|June 1, 2014
Effect of vitamin D supplementation on orthostatic hypotension: data from the vitamin D in isolated systolic hypertension randomized controlled trialMiles D Witham, Rosemary J G Price, Allan D Struthers, et al.
Archives of Internal Medicine|November 26, 2008
Statins and blood pressureStella Trompet, J Wouter Jukema, Ian Ford, et al.
BMC Cardiovascular Disorders|May 11, 2007
Does the aldosterone:renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) studyHari K Parthasarathy, Khamis Alhashmi, Alex D McMahon, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 26, 2014
Associations Between Thrombin Generation and the Risk of Cardiovascular Disease in Elderly Patients: Results From the PROSPER StudyRinske Loeffen, Kristien Winckers, Ian Ford, et al.
BMJ Open|September 10, 2016
Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART studyIsla S Mackenzie, Ian Ford, Andrew Walker, et al.
ESC Heart Failure|July 10, 2023
Efficacy of ivabradine in heart failure patients with a high-risk profile (analysis from the SHIFT trial)Amr Abdin, Michel Komajda, Jeffrey S Borer, et al.
Pageof 51